CMS Entry id: 2710 | Channel: News landing page | Template: news/index

Facebook YouTube Twitter Linkedin
Facebook YouTube Twitter Linkedin


20 December 2013

Canterbury and Coastal: Working to improve dementia diagnosis

GP practices in the Canterbury and Coastal area are piloting Cantab Mobile to help staff detect the earliest signs of memory problems for their patients.

3 December 2013

Cognitive impairment in depression: a core feature and valuable target for future interventions

Scientists at Cambridge Cognition recently published a review paper addressing the important question of whether cognitive impairment should be considered a core feature of depression.

29 November 2013

Addressing dementia as a lifelong and preventable condition

Dementia is a major public health problem that poses an increasing burden on the health and wealth of societies worldwide. Rebalancing efforts from the development of treatments to increased emphasis on prevention may be an alternative means to reducing the impact of dementia on society.

29 November 2013

Half of dementia sufferers ‘not being formally diagnosed’

The health secretary has revealed less than half of people suffering from dementia are being diagnosed and joined the growing support for early diagnosis of the condition.

27 October 2013

Cambridge Cognition attend the year’s premier neuroscience event

Cambridge Cognition will be in attendance at the 43rd annual meeting of the Society for Neuroscience. Booth 414 will host live demonstrations of Eclipse™ 6 - the latest version of the leading software in cognitive research, powered by Cantab® Technology.

11 October 2013

Correlation demonstrated between cognitive performance assessed with CANTAB schizophrenia battery and MCCB in Phase 2 clinical trials

Cambridge Cognition presents a comparison of the Cantab schizophrenia battery and the MCCB at the International Society for CNS Clinical Trials and Methodology Autumn conference.